These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33909256)

  • 1. Comorbidities impact and de-prescribing in elderly with HCV-related liver disease: analysis of a prospective cohort.
    Licata A; Minissale MG; Giannitrapani L; Montalto FA; Lombardo C; Mirarchi L; Amodeo S; Soresi M; Montalto G
    Intern Emerg Med; 2022 Jan; 17(1):43-51. PubMed ID: 33909256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
    Kondili LA; Gaeta GB; Ieluzzi D; Zignego AL; Monti M; Gori A; Soria A; Raimondo G; Filomia R; Di Leo A; Iannone A; Massari M; Corsini R; Gulminetti R; Gatti Comini A; Toniutto P; Dissegna D; Russo FP; Zanetto A; Rumi MG; Brancaccio G; Danieli E; Brunetto MR; Weimer LE; Quaranta MG; Vella S; Puoti M
    PLoS One; 2017; 12(2):e0172159. PubMed ID: 28245248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication use and medical comorbidity in patients with chronic hepatitis C from a US commercial claims database: high utilization of drugs with interaction potential.
    Lauffenburger JC; Mayer CL; Hawke RL; Brouwer KL; Fried MW; Farley JF
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1073-82. PubMed ID: 25014625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016.
    Ruzicka DJ; Tetsuka J; Fujimoto G; Kanto T
    BMC Infect Dis; 2018 May; 18(1):237. PubMed ID: 29793436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidities and concomitant medications in patients with chronic hepatitis C virus infection receiving second-generation direct-acting antiviral regimens in Belgium: an observational study.
    Bourgeois S; Mulkay JP; Cool M; Verhelst X; Robaeys G; Lasser L; Lefebvre V; Colle I; Van Steenkiste C; Decaestecker J; Coulon S; Venken K; Vanwolleghem T
    Acta Gastroenterol Belg; 2021; 84(1):33-41. PubMed ID: 33639691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan.
    Liu CH; Yu ML; Peng CY; Hsieh TY; Huang YH; Su WW; Cheng PN; Lin CL; Lo CC; Chen CY; Chen JJ; Ma Q; Brooks-Rooney C; Kao JH
    Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1290-1300. PubMed ID: 30362139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidities and Prescribed Medications in Korean Patients with Chronic Hepatitis C: A Nationwide, Population-Based Study.
    Chung JW; Choi HY; Ki M; Jang ES; Jeong SH
    Gut Liver; 2021 Mar; 15(2):295-306. PubMed ID: 32616682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life study.
    Pugliese N; Giorgini A; Maggi D; Capogreco A; Dibenedetto C; Lubrano Lobianco F; Dal Buono A; Monico S; Meli R; Battezzati PM; Lleo A; De Santis A; Zuin M; Aghemo A
    Expert Opin Drug Saf; 2021 Jul; 20(7):839-843. PubMed ID: 33881366
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.
    Merli M; Frigeni M; Alric L; Visco C; Besson C; Mannelli L; Di Rocco A; Ferrari A; Farina L; Pirisi M; Piazza F; Loustaud-Ratti V; Arcari A; Marino D; Sica A; Goldaniga M; Rusconi C; Gentile M; Cencini E; Benanti F; Rumi MG; Ferretti VV; Grossi P; Gotti M; Sciarra R; Tisi MC; Cano I; Zuccaro V; Passamonti F; Arcaini L
    Oncologist; 2019 Aug; 24(8):e720-e729. PubMed ID: 30552159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.
    Ferrarese A; Germani G; Gambato M; Russo FP; Senzolo M; Zanetto A; Shalaby S; Cillo U; Zanus G; Angeli P; Burra P
    World J Gastroenterol; 2018 Oct; 24(38):4403-4411. PubMed ID: 30344424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real life experience with direct-acting antivirals agents against hepatitis C infection in elderly patients.
    Rodríguez-Osorio I; Cid P; Morano L; Castro Á; Suárez M; Delgado M; Margusino L; Meijide H; Pernas B; Tabernilla A; Pedreira JD; Mena Á; Poveda E
    J Clin Virol; 2017 Mar; 88():58-61. PubMed ID: 28183063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study.
    Romano A; Angeli P; Piovesan S; Noventa F; Anastassopoulos G; Chemello L; Cavalletto L; Gambato M; Russo FP; Burra P; Vincenzi V; Scotton PG; Panese S; Tempesta D; Bertin T; Carrara M; Carlotto A; Capra F; Carolo G; Scroccaro G; Alberti A
    J Hepatol; 2018 Aug; 69(2):345-352. PubMed ID: 29551707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
    Degasperi E; D'Ambrosio R; Iavarone M; Sangiovanni A; Aghemo A; Soffredini R; Borghi M; Lunghi G; Colombo M; Lampertico P
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1183-1191.e7. PubMed ID: 30613002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of direct acting antiviral treatment and clinical significance of drug-drug interactions in elderly patients with chronic hepatitis C virus infection.
    Vermehren J; Peiffer KH; Welsch C; Grammatikos G; Welker MW; Weiler N; Zeuzem S; Welzel TM; Sarrazin C
    Aliment Pharmacol Ther; 2016 Oct; 44(8):856-65. PubMed ID: 27549000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect.
    Smolders EJ; Smit C; de Kanter C; Dofferhoff A; Arends JE; Brinkman K; Rijnders B; van der Valk M; Reiss P; Burger DM;
    HIV Med; 2018 Mar; 19(3):216-226. PubMed ID: 29194939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients.
    Cheng CH; Chu CY; Chen HL; Lin IT; Wu CH; Lee YK; Bair MJ
    Front Endocrinol (Lausanne); 2021; 12():799382. PubMed ID: 35095765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort.
    Verna EC; Morelli G; Terrault NA; Lok AS; Lim JK; Di Bisceglie AM; Zeuzem S; Landis CS; Kwo P; Hassan M; Manns MP; Vainorius M; Akushevich L; Nelson DR; Fried MW; Reddy KR
    J Hepatol; 2020 Sep; 73(3):540-548. PubMed ID: 32243960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of the potential drug-drug interactions between pangenotypic direct-acting antivirals and the concomitant medications associated with patients with chronic hepatitis C virus infection in Spain.
    Sicras Mainar A; Navarro Artieda R; Hernández I; Morillo R
    Gastroenterol Hepatol; 2019 Oct; 42(8):465-475. PubMed ID: 31451229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced immune responses, PI3K/AKT and JAK/STAT signaling pathways following hepatitis C virus eradication by direct-acting antiviral therapy among Egyptian patients: a case control study.
    Ramadan HK; Badr G; Ramadan NK; Sayed A
    Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33524139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comorbidities and concomitant medication use in adult patients with chronic hepatitis C: a descriptive epidemiological analysis].
    Wang Q; Rao HY; Yu N; Gao SQ; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):225-232. PubMed ID: 29804396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.